NCT06362629 · RECRUITING
AI App for Management of Atopic Dermatitis
This trial is testing a smartphone app that uses artificial intelligence to help patients manage atopic dermatitis, a chronic inflammatory skin condition. The app is designed to guide both patients and doctors through a structured treatment approach, improve medication adherence, and track disease severity over time. This is a Phase NA randomized controlled trial, meaning it is evaluating a behavioral tool rather than a drug, and results are not yet established.
You may qualify if
- Diagnosed with AD, aged 1~75 years; be able to communicate in Chinese; with basic reading and writing skills; participants or the guardian have smartphones or pads and are familiar with the use skills.
You're excluded if
- Mental illness; personality disorder; language barrier; hearing impairment; communication difficulties; with serious coexisting diseases, such as cardiopulmonary insufficiency, liver dysfunction, renal dysfunction, blood system diseases, tumors, or other diseases; other situations that not suitable for participating in clinical trial.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-10-15